<SEC-DOCUMENT>0001193125-17-229404.txt : 20170717
<SEC-HEADER>0001193125-17-229404.hdr.sgml : 20170717
<ACCEPTANCE-DATETIME>20170717164602
ACCESSION NUMBER:		0001193125-17-229404
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20170712
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20170717
DATE AS OF CHANGE:		20170717

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MANNKIND CORP
		CENTRAL INDEX KEY:			0000899460
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				133607736
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50865
		FILM NUMBER:		17967896

	BUSINESS ADDRESS:	
		STREET 1:		25134 RYE CANYON LOOP
		STREET 2:		SUITE 300
		CITY:			VALENCIA
		STATE:			CA
		ZIP:			91355
		BUSINESS PHONE:		6617755300

	MAIL ADDRESS:	
		STREET 1:		25134 RYE CANYON LOOP
		STREET 2:		SUITE 300
		CITY:			VALENCIA
		STATE:			CA
		ZIP:			91355
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d406524d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>WASHINGTON, D.C. 20549 </B></P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B><FONT
STYLE="white-space:nowrap">FORM&nbsp;8-K</FONT> </B></P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT
REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant to Section&nbsp;13 or 15(d) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>of the Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (Date of earliest event reported): July&nbsp;12, 2017 </B></P>
<P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>MannKind Corporation </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">000-50865</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">13-3607736</FONT></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>incorporation or organization)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Commission</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>File Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(IRS Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>25134 Rye Canyon Loop, Suite 300</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Valencia, California</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>91355</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center"><B>(Address of principal executive offices)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Zip Code)</B></TD></TR>
</TABLE> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Registrant&#146;s telephone number, including area code:
<FONT STYLE="white-space:nowrap">(661)&nbsp;775-5300</FONT> </B></P> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>N/A </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Former name or former address, if changed since last report.) </B></P>
<P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the <FONT STYLE="white-space:nowrap">Form&nbsp;8-K&nbsp;is</FONT> intended to simultaneously satisfy the filing obligation
of the registrant under any of the following provisions (see General Instruction A.2. of <FONT STYLE="white-space:nowrap">Form&nbsp;8-K):</FONT> </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top">Soliciting material pursuant to <FONT STYLE="white-space:nowrap">Rule&nbsp;14a-12&nbsp;under</FONT> the Exchange Act (17 <FONT STYLE="white-space:nowrap">CFR&nbsp;240.14a-12)</FONT> </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="white-space:nowrap">Pre-commencement&nbsp;communications</FONT> pursuant to <FONT STYLE="white-space:nowrap">Rule&nbsp;14d-2(b)&nbsp;under</FONT> the Exchange Act (17
<FONT STYLE="white-space:nowrap">CFR&nbsp;240.14d-2(b))</FONT> </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="white-space:nowrap">Pre-commencement&nbsp;communications</FONT> pursuant to <FONT STYLE="white-space:nowrap">Rule&nbsp;13e-4(c)&nbsp;under</FONT> the Exchange Act (17
<FONT STYLE="white-space:nowrap">CFR&nbsp;240.13e-4(c))</FONT> </TD></TR></TABLE> <P STYLE="margin-top:10pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405 of this chapter) or Rule <FONT STYLE="white-space:nowrap">12b-2</FONT> of the Securities Exchange Act of 1934 (&#167;
<FONT STYLE="white-space:nowrap">240.12b-2</FONT> of this chapter). </P> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section&nbsp;13(a) of the Exchange Act.&nbsp;&nbsp;&#9744; </P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="12%" VALIGN="top" ALIGN="left"><B>Item&nbsp;5.02</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </B></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On July&nbsp;12, 2017, we appointed Steven Binder as our Chief Financial Officer and our principal accounting officer, replacing Rosabel Alinaya in such
capacities, effective upon his commencement of employment with us on July&nbsp;17, 2017. Ms.&nbsp;Alinaya will serve as our Senior Vice President, Investor Relations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Before joining MannKind Corporation, Mr.&nbsp;Binder, age 54, served as Vice President and Chief Financial Officer of the International Group of Stryker
Corporation, a medical device and equipment manufacturing company based out of Singapore, since 2013. Prior to Stryker Corporation, Mr.&nbsp;Binder served in a series of senior leadership roles at Bristol-Myers Squibb Company (&#147;BMS&#148;). His
last four positions at BMS were Vice President, Finance roles over the following geographic operating units: United States from 2012 to 2013, Europe from 2008 to 2011, Asia Pacific from 2005 to 2007 and Japan from 2003 to 2005. Prior to that,
Mr.&nbsp;Binder served in three senior leadership roles for Oncology Therapeutics Network (&#147;OTN&#148;), a U.S.-based independent subsidiary of BMS: Vice President, Strategic Development from 2001 to 2003, Vice President, Customer Operations
from 2000 to 2001 and Chief Financial Officer from 1997 to 2000. Before OTN, Mr.&nbsp;Binder completed three finance and accounting roles for BMS Worldwide Medicines Group after joining BMS in 1992. Before BMS, he worked for Deloitte&nbsp;&amp;
Touche LLP in a series of auditing roles over an eight year period beginning in 1984. Mr.&nbsp;Binder received a B.S. degree in Accounting and Business Administration from Muhlenberg College and is a Certified Public Accountant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with his appointment as our Chief Financial Officer, we entered into an offer letter agreement with Mr.&nbsp;Binder pursuant to which we agreed
to provide Mr.&nbsp;Binder with the following compensation: (i)&nbsp;annual base salary of $400,000; (ii) a <FONT STYLE="white-space:nowrap">one-time</FONT> <FONT STYLE="white-space:nowrap">sign-on</FONT> bonus of $50,000, subject to repayment under
certain conditions; (iii)&nbsp;eligibility to receive annual discretionary bonuses, with an annual target performance-bonus opportunity of 50% his base salary; and (iv)&nbsp;subject to the approval by our board of directors, the grant of a stock
option to purchase 180,100 shares of our common stock under our 2013 Equity Incentive Plan (the &#147;Plan&#148;), with such shares vesting in four equal installments upon the achievement of specified quarterly product sales. In accordance with the
Plan, the stock option shall have an exercise price equal to the closing price of our common stock on the date of grant. The foregoing stock option will be evidenced by a Stock Option Grant Notice and Option Agreement (collectively, the &#147;Grant
Documents&#148;), which, together with the Plan, will set forth the terms and conditions of the stock option. The foregoing description of the stock option does not purport to be complete and is qualified in its entirety by reference to the Plan,
filed as Exhibit 10.1 to our Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;000-50865),</FONT> filed with the Securities and Exchange Commission (&#147;SEC&#148;) on
August&nbsp;9, 2016, and the forms of Grant Documents under the Plan, filed as Exhibits 99.2 and 99.3 to our Registration Statement on Form <FONT STYLE="white-space:nowrap">S-8</FONT> (File
<FONT STYLE="white-space:nowrap">No.&nbsp;333-188790),</FONT> filed with the SEC on May&nbsp;23, 2013. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Binder will also be entitled to enter
into our standard form of indemnity agreement, a copy of which is attached as Exhibit 10.1 to our Registration Statement on Form <FONT STYLE="white-space:nowrap">S-1</FONT> <FONT STYLE="white-space:nowrap">(File&nbsp;No.&nbsp;333-115020),</FONT>
filed with the SEC on April&nbsp;30, 2004, and our standard form of change of control agreement, a copy of which is attached as Exhibit 99.1 to our Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> (File <FONT
STYLE="white-space:nowrap">No.&nbsp;000-50865),</FONT> filed with the SEC on April&nbsp;7, 2017. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing description of the offer letter agreement
with Mr.&nbsp;Binder does not purport to be complete and is qualified in its entirety by reference to the agreement, a copy of which is attached as Exhibit 99.1 to this report. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="12%" VALIGN="top" ALIGN="left"><B>Item&nbsp;9.01</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Financial Statements and Exhibits. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:28.45pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit<BR>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:39.50pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Offer Letter Agreement, dated July&nbsp;12, 2017, by and between MannKind Corporation and Steven Binder.</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="45%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"><B>MANNKIND CORPORATION</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dated: July&nbsp;17, 2017</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ David Thomson</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">David Thomson, Ph.D., J.D.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Corporate Vice President, General Counsel and Secretary</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:28.45pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit<BR>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:39.50pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Offer Letter Agreement, dated July&nbsp;12, 2017, by and between MannKind Corporation and Steven Binder.</TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d406524dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="80%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g406524img1.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;<BR> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></P>
<P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></P></TD>
<TD VALIGN="top" ALIGN="right">One Casper Street<BR> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Danbury, CT 06810</P>
<P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Main: 203-798-8000</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Fax:
203-798-7740</P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.mannkindcorp.com</P></TD>
<TD NOWRAP VALIGN="top">&nbsp;<BR> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;</P>
<P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;</P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">July&nbsp;12, 2017 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Steven&nbsp;B. Binder </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Steve, </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Congratulations! The MannKind team has been very impressed with your background and credentials, and we are genuinely pleased to offer you full-time employment
with MannKind Corporation, in the exempt position Chief Financial Officer located in California. In this position you will initially report directly to Michael Castagna, Chief Executive Officer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will target your employment to commence on July&nbsp;17, 2017. Please be advised that continued employment is contingent upon satisfactory reference and
background checks and receipt of results of a satisfactory drug screening test. You will receive an email with information regarding the test, contact and location information for the laboratory as well as the hours of operation. This screening test
must be completed within two weeks from the date of this letter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You will be paid on a bi-weekly basis, on regular payroll schedule, in the amount of
$15,384.62, equating to an annualized amount of $400,000.12. You will be eligible to participate in the MannKind Discretionary Bonus Plan, with a target bonus opportunity of 50% of annual earnings. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, you will receive a one-time sign-on bonus in the gross amount of $50,000.00, less appropriate withholdings and other payroll deductions, payable
as a lump sum on the first pay period at the end of the first ninety (90)&nbsp;days of your employment. By accepting this offer, you agree that, in the event that you voluntarily leave the Company, or if you are terminated by the Company for
&#147;cause&#148;, within the twelve (12)&nbsp;months following receipt of payment, you will repay the full amount of the payment, net any with-holdings within thirty (30)&nbsp;days after the last day of your employment. By accepting this offer, you
further agree that the Company may deduct this amount from any other amounts The Company owes you should you be obligated to repay this amount. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You will
be eligible to participate in the 2017 MannKind Equity Program, under which Performance-based Stock Options will be awarded to you at a future date, as approved by the Board of Directors. At the next quarterly Board meeting after your hire date, we
will recommend that you be granted an equity award of 180,100 units of Performance-based Stock Options which is comparable to grants made for other individuals in similar level positions throughout the company. This is not a guarantee for a specific
number of stock units, but is only intended to provide you with an understanding of grant guidelines for your position. If your start date is less than two weeks prior to the next quarterly Board meeting, the </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Steven B. Binder, pg 2 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">recommendation will be submitted in the following quarter. Grants will begin vesting based on your hire date
and upon the organization reaching specific sales milestones. You will also be eligible for an annual equity grant moving forward. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Included as part of
this offer is information about the main points of the Company&#146;s relocation assistance program, which MannKind will provide to you to relocate to the &#147;local area.&#148; Upon acceptance of this offer, a representative of NEI will contact
you to initiate your relocation benefits. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MannKind will provide relocation assistance to you in good faith, however, should you leave the Company before
one year for any reason, except layoff, you will be required to repay the Company all funds paid, either to you or on your behalf, for relocation purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have a substantial list of fringe benefits, including the following: 20 days PTO annually, which accrues on a bi-weekly basis; short term and long term
disability insurance; company-paid life insurance; a 401(k) tax deferred savings program; flexible spending accounts; health, vision and dental insurance, Executive Medical Reimbursement plan and paid holidays which includes a full week in July and
December for the holiday break. The holidays and other time off benefits will be prorated based on your date of hire. All benefits, policies and rules are subject to change from time to time at the Company&#146;s discretion. All benefits outlined in
this offer letter are contingent on your continuing employment with MannKind Corporation in a benefit eligible status. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Shortly after we are in receipt of
your acceptance, you will receive a welcome email from our onboarding manager, with a link to your personalized onboarding portal. Through this portal you will have access to most of the required MannKind policies and agreements that will require
your signature such as, the Employee Proprietary Information and Invent ions Agreement, an Arbitration Agreement, a Policy Against Insider Trading, Code of Business Conduct and Ethics, and an Employee Acknowledgement Form, required after reading the
MannKind Employee Sourcebook. Of course, the company may require additional policies or agreements to be signed and acknowledged in the future. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Employment at MannKind is at will, which means that either you or MannKind can end the employment relationship at any time, and for any reason or for no
reason, with or without cause or notice. The employment terms in this letter supersede any other agreements or promises made to you by anyone, whether oral or written, and cannot be modified or amended except in writing by an officer of the company.
As required by law, this offer is subject to satisfactory proof of your right to work in the United States. This at will employment relationship cannot be changed except in writing as approved by the Board of Directors of MannKind. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We appreciate the energy and enthusiasm you demonstrated during our interview and selection process and we look forward to a favorable response to our offer.
We have many exciting challenges ahead and believe you can make a significant contribution to MannKind. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At your earliest convenience, please sign and
date this letter and return to me to indicate your acceptance of this written offer of employment. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Steven B. Binder, pg 2 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you should have any questions, please don&#146;t hesitate to contact me. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sincerely, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>/s/ Diana Champagne </U></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Diana Champagne </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Director, Total Rewards and HR Ops </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I have carefully read and understand all of the terms of the above letter and freely and voluntarily accept and agree to all of its terms. I represent that,
in agreeing to this offer letter, I am not relying on any representations or promises of any kind other than set forth in this letter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>/s/ Steven B.
Binder </U></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Steven B. Binder </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>July&nbsp;12, 2017 </U>
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date Signed </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>July&nbsp;17, 2017 </U> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Confirmed Start Date </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g406524img1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g406524img1.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 1 #] P$1  (1 0,1 ?_$ *H  0 " @(# 0$
M       ("0<*!08!! L" P$!  (" P$!              8'!0@" P0!"1
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MI*Q"]:K"W;QJB,P0I"G'N"<O2 "(E 9_R[MYE.*Y:#A4K3,FSXK;S:6DJO\
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MIN2V"#M]FM[:V ()J_/=T/I,VYQOC&-DY;+L6]4-D(:;N+V4X0H;OLM>X!W
M@94X5^3.F\J<C7'CYD#$^0>,_*"@1@3=APID]NF5](P.Z0*V"GS":34MBAF_
MN$A.M[=#<BI%" =,P'UBN:=M)G%L<SR#'RX^3XQ(5M1)8.@5_ XG78HV.ESJ
M"#8Z5D^(=PXO)9SN$GQ7\=R-A.Y4=[J4_P 2%:;D]-;#0W%QK5F^X;[;AO\
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M$IO<H'0FW6N#N<<;Y&S@1%D*9=C*=^H"3Z*2%;?34KH%GJ!?I4C]PWVW#?\
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M;337.JF0QR"&KQGY?A>-Y!B(N046>9SL,AF/((W(C)*5>FH;O*E2G"H VN2
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MTR6C%JX['=>0VZM!=T5=*BDC11L5'KIH17KO<J96\?\ ">;S"6#<DY)D\?\
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M)?-%\MW*K*O*>)7K6<LKY11:-)6SU Z!T6U1CX:,44CH2%9"IW"D2'U5(0P
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MI=DDJ5"\-,7W?%5'QC'0T<XA9V$N46A%F=R<P=9%XS>L"H=TPI(F]RJ<QC"
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M -  .@ ]E>K+RK&#C'LO)*BBQCVZCEPH!#*' A _I33( G554-L4A2@(F,(
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>E*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4K__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
